Adverum Biotechnologies(us:ADVM)
3.86
-2.03%
Updated on 2025-04-04
Open:3.79
Close:3.86
High:4.01
Low:3.76
Prev Close:3.94
Volume:142272.00
Turnover:546819.06
Turnover Ratio:0.68%
Shares:20.80M
MarketCap:80.30M
About Adverum Biotechnologies
Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company that engages in the development of gene therapies for ocular and rare diseases. The company was founded by Mark S. Blumenkranz, Thomas W. Chalberg, Jr., Mitchell H. Finer, and Steven Daniel Schwartz on July 17, 2006 and is headquartered in Redwood City, CA.
Company Name: Adverum Biotechnologies
Address: 100 Cardinal Way
Employees: 121
Fiscar Year: 12-31
IPO Date: 2014-07-31
Website: http://www.adverum.com
CIK: 1501756
View all SEC Filings
About
Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company that engages in the development of gene therapies for ocular and rare diseases. The company was founded by Mark S. Blumenkranz, Thomas W. Chalberg, Jr., Mitchell H. Finer, and Steven Daniel Schwartz on July 17, 2006 and is headquartered in Redwood City, CA.
Address:100 Cardinal Way
Website:http://www.adverum.com
Market Movers